Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage

  title={Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage},
  author={Obinna Ikechukwu Ekwunife and Stefan K. Lhachimi},
  journal={BMC Health Services Research},
BackgroundWorld Health Organisation recommends routine Human Papilloma Virus (HPV) vaccination for girls when its cost-effectiveness in the country or region has been duly considered. We therefore aimed to evaluate cost-effectiveness of HPV vaccination in Nigeria using pragmatic parameter estimates for cost and programme coverage, i.e. realistically achievable in the studied context.MethodsA microsimulation frame-work was used. The natural history for cervical cancer disease was remodelled from… 
Economic evaluation of human papillomavirus vaccination in the Global South: a systematic review
A wide range in the cost-effectiveness ratio was observed in the included studies due to different study settings, populations, and inconsistencies in modeling practices (variations in methodological approaches).
Economic Evaluation of Vaccination Programs: A Guide for Selecting Modeling Approaches.
Appraisal of willingness to vaccinate daughters with human papilloma virus vaccine and cervical cancer screening uptake among mothers of adolescent students in Abakaliki, Nigeria
Education, screening status, mother–daughter vaccination status, and willingness to encourage others on HPV vaccine for daughters were significantly associated with HPV awareness, but they lack awareness and the financial resources for the access.
Men's willingness to support HPV vaccination and cervical cancer screening in Nigeria.
Nigerian men's willingness to encourage and pay for family member to obtain HPV vaccine and cervical screening supports the findings that lack of male involvement may be an overlooked obstacle to cervical cancer prevention in developing countries.
Correlates of human papillomavirus vaccine knowledge and acceptability among medical and allied health students in Northern Nigeria
The majority of medical and allied health students in Kano, Nigeria, were willing to receive HPV vaccination, despite their sub-optimal level of knowledge and low vaccine uptake, as HPV vaccine uptake is scaled up across Africa.
Predictors of uptake of cervical cancer screening among nurses in Ogbomoso, Nigeria
Good knowledge of nurses on cervical cancer screening does not translate to uptake of screening services, and it is recommended that cervical and other cancer screening services should be included in the pre-employment medical examination of nurses to compel usage of screenings services.
Addressing missed opportunities for cervical cancer screening in Nigeria: a nursing workforce approach
The current status of cervical cancer screening in Nigeria is highlighted, the role of female nurses is contextualised, and novel approaches to address missed opportunities for screening by leveraging the nursing workforce are proffered.
Re-thinking breast and cervical cancer preventive campaigns in developing countries: the case for interventions at high schools
A case is made for enlightenment campaigns to primarily target teenagers in high schools of developing countries, given that both cancers take hold on populations within that age bracket, andclusions into the schools’ academic curricula are the recommended approach.
Thou shalt be given… but how? A replication study and extended cost-effectiveness analysis of a randomized experiment on food assistance in Northern Ecuador
ABSTRACT The original cluster-randomised controlled trial took place in two provinces of Northern Ecuador. The trial compared cash, food or voucher assistance and found them to be effective. The
Factors influencing cervical cancer screening practice among female health workers in Nigeria: A systematic review
To reduce the burden of cervical cancer in Nigeria, female health workers are expected to play an influential role in leading screening uptake and promoting access to cervical cancer education and screening.


Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations
Assessment of how context-specific challenges of implementing cervical cancer prevention strategies in LMICs were accounted for in existing cost-effectiveness analysis models of human papillomavirus (HPV) vaccination found greater efforts need to be made in adapting models to account for these challenges.
Cost-Effectiveness Analysis of the Bivalent and Quadrivalent Human Papillomavirus Vaccines from a Societal Perspective in Colombia
HPV vaccination could be a convenient alternative for the prevention of CC in Colombia, however, the price of the vaccine should be lower for this vaccination strategy to be cost-effective.
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.
It is predicted that a vaccine that prevents persistent HPV16/18 infection will reduce the incidence of HPV 16/18-associated cervical cancer, even in a setting of cytologic screening.
Health and economic impact of human papillomavirus 16 and 18 vaccination of preadolescent girls and cervical cancer screening of adult women in Peru.
Preadolescent HPV vaccination, followed by enhanced HPV DNA screening in adult women, could prevent two out of three cervical cancer deaths and should motivate creative mechanisms for financing and scale-up of delivery programs.
Cost-effectiveness of HPV 16, 18 vaccination in Brazil.
Cost-effectiveness of cervical-cancer screening in five developing countries.
Cervical-cancer screening strategies incorporating visual inspection of the cervix with acetic acid or DNA testing for HPV in one or two clinical visits are cost-effective alternatives to conventional three-visit cytology-based screening programs in resource-poor settings.